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According to the South African (SA) National Cancer Registry 2009, 
prostate cancer is the most commonly diagnosed solid-organ cancer 
in SA men.[1] The incidence of prostate cancer in SA increases at ~3% 
every year and 1/26 men are at risk of developing cancer in their 
lifetime.[1] Five men die of prostate cancer in SA every day.[1]
The American Urology Association guidelines recommend 
individualised screening for prostate cancer in men ˂55 years 
of age, based on high risk (positive family history or African 
American race).[2] For men aged 55 - 69 years, they recommend 
shared decision-making based on values and preferences.[2] The 
US Preventive Services Task Force has a grade D recommendation 
against prostate cancer screening, but concerns have recently been 
raised that these cancers may be of a higher grade and stage on 
subsequent detection.[3,4]
Screening for prostate cancer in SA public hospital settings 
entails a digital rectal examination (DRE) and serum prostate-
specific antigen (PSA) testing. Most prostate cancers are located in 
the peripheral zone of the prostate and may be detected by a DRE 
when the volume is ≥0.2 mL.[5] In ~18% of all patients, prostate 
cancer is detected by a suspect DRE alone, irrespective of the serum 
PSA level.[5] An abnormal DRE is associated with an increased risk 
of a higher Gleason score and should therefore be considered an 
indication for prostate biopsy.[5] A PSA level >4 ng/mL is consid-
ered abnormal. Each test (DRE and PSA) identifies a proportion of 
cancers, with greater rates of detection when used in combination. 
A positive finding on DRE when combined with an elevated PSA 
level increases the positive predictive value of detecting cancer on 
prostate biopsy by 26.2% compared with an elevated PSA level but 
a normal prostate on DRE.[6]
Some studies have found the DRE to be of limited value. The 
Prostate, Lung, Colorectal and Ovarian Cancer Screening trial found 
no long-term benefit with DRE and PSA testing. A suspect DRE in 
patients with a PSA level ≤2 ng/mL has a positive predictive value of 
5 - 30%.[5] DRE has a sensitivity of 55 - 68% in asymptomatic men, 
but values as low as 18 - 22% have been reported.[7] Bretton[8] found 
that of 8% (n=60) of men with abnormal DRE findings and a normal 
PSA, only 3% (n=2) had prostate cancer.
DRE could prove beneficial in detecting other pathological con-
ditions, e.g. occult blood in the stool suggestive of colon or rectal 
cancer, other colorectal pathology, and benign prostatic hyperplasia.
There is a high concordance of abnormal DRE results between 
general practitioners and urologists, which supports the finding that 
general practitioners or other non-urologists should always perform 
DREs as part of their examination for the early detection of cancer.[9] 
However, such doctors may not have the time to do routine screening 
owing to large patient loads and minimal time allowed with each 
patient. In overcrowded casualty settings, doctors may also not have 
the appropriate privacy for intimate examinations.
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Background. According to the South African (SA) National Cancer Registry 2009, prostate cancer is the most commonly diagnosed solid-
organ cancer in SA men: the incidence increases at ~3% every year, with 1/26 men developing prostate cancer in their lifetime and five men 
dying every day. Screening for prostate cancer by performing a digital rectal examination (DRE) adds to the sensitivity and specificity of 
serum prostate-specific antigen (PSA) testing and is an important component of the assessment for the early detection of prostate cancer.
Objectives. To ascertain whether doctors who are not in the field of urology perform DREs and PSA testing to screen for prostate cancer, 
where indicated, and to determine the reason, if any, why doctors do not perform prostate examinations.
Methods. Doctors (including specialists and primary care practitioners) who consulted adult male patients in the emergency departments 
and polyclinics of three academic hospitals were included in the sample and asked to complete an anonymous questionnaire. Doctors with 
specialist urological training were excluded from the sample. The questionnaire included the following aspects: gender, year of graduation 
and university, current position, knowledge of PSA screening and DRE, whether these were being performed, and reasons for non-
performance.
Results. The response rate was 303/350 participants. Fifty-nine percent of the respondents were female. The median duration of experience 
was 5 years. The mean (standard deviation) knowledge score with regard to screening was 56.1% (20). The PSA test alone was most 
frequently done (35%), followed by asking the patient about urinary tract symptoms (28%). In contrast, DRE of the prostate, alone or 
combined with a PSA test, was performed less frequently (13.2% and 10.6%, respectively). Some of the most common reasons for not 
performing a DRE included: ‘It’s more convenient to do a PSA test’; ‘Urologists will examine the prostate anyway’; ‘No privacy in the 
emergency department/admission ward’; ‘Prostate exam is not relevant to my practice’; ‘There is not enough time’; and ‘The practitioner 
forgets’. Doctors with >7 years of working experience are the least likely to do a DRE.
Conclusion. Performance rates of DRE and PSA testing by doctors who are not urologists are very low, which may have significant clinical 
implications. It is recommended that SA prostate cancer screening guidelines are necessary to change practice with regard to this condition.
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The objective of this study was therefore to 
ascertain whether SA doctors who are not in 
the field of urology perform DREs to assess 
the prostate for cancer, where indicated. 
The study also aimed to determine the 
reason why doctors do not perform prostate 
examinations at the academic hospitals, as 
mentioned below.
Methods 
Sample size
Sample size was calculated using estimates of 
50%, with a 5% precision and a 95% confidence 
level. A sample size of 385 was required. 
Study participants
The duration of experience was estimated 
as the number of years between graduation 
and the beginning of 2016, as the survey 
was done in the first 6 months of 2016. The 
doctor had to consult adult male patients; 
specialists and primary care practitioners 
working in emergency departments and 
polyclinics were also included. Doctors with 
specialist urological training were not part of 
the sample. Doctors from three University of 
the Witwatersrand academic hospitals were 
included: Charlotte Maxeke Johannesburg 
Academic Hospital, Helen Joseph Hospital, 
and Chris Hani Baragwanath Hospital. 
Permission was obtained from the dean 
of the Faculty of Health Sciences and the 
manage ment at each hospital. Ethics appro-
val was obtained from the Human Research 
Ethics Committee at the University of the 
Witwatersrand (ref. no. M151102).
Data collection process/tool
Doctors were approached by the researcher 
and given an information sheet before an 
academic meeting. The participants com-
pleted an anonymous questionnaire that was 
divided into four domains: the respondent’s 
demographics; knowledge of prostate cancer 
assessment; practice of DRE and PSA testing; 
and reasons for non-performance of a DRE. 
Completing the questionnaire was voluntary 
and considered to presume consent. Doctors’ 
names and the hospitals were not recorded 
on the questionnaire to maintain anonymity. 
The knowledge score was calculated by scor-
ing the responses as 1 for each correct answer 
to each of the 8 items in questions 6 - 8, thus 
creating a score out of 8 (Table 1). This was 
then converted to a percentage.
The questionnaire was based on similar 
questionnaires from other studies.[10-12] It was 
modified to the SA context by adding more 
reasons for non-performance of the DRE, 
such as no lubrication jelly and no space to 
examine the patient in the admission ward. 
The questionnaire was then piloted on a 
small cohort of doctors to check for validity 
of the modifications. The completed forms 
were placed in a sealed box in an adminis-
trator’s office to further protect the respon-
dents’ identities. A total of 350 question-
naires were handed out.
Statistical analysis
Descriptive analysis of the data was car-
ried out as follows: categorical variables 
were summarised by frequency and percent-
age tabulation and illustrated by bar charts. 
Continuous variables were summarised by 
the mean, standard deviation (SD), median 
and interquartile range (IQR), and their 
distribution was illustrated by histograms.
The χ2 test was used to assess the relation-
ship between categorical study variables and 
gender, duration of experience, undergradu-
ate university and field of practice. Fisher’s 
exact test was used for 2 × 2 tables or where 
the requirements for the χ2 test could not be 
met. The strength of the associations was 
measured by Cramér’s V and the phi coeffi-
cient, respectively. 
The relationship between knowledge score 
and gender, duration of experience, under-
graduate university, field of practice and prac-
tice was assessed by the t-test (or analysis of 
variance (ANOVA) for more than two cate-
gories). The strength of the associations was 
measured by Cohen’s d for parametric tests and 
the r-value for the non-parametric tests. 
Data were analysed using SAS 9.4 (SAS 
Institute Inc., USA) (5% signifi cance level).
Results
The response rate was 303/350 question-
naires completed (86.6%). The majority of 
the respondents were female (59.1%). The 
median duration of experience was 5 years 
(IQR 2 - 9 years; range 0 - 48 years). Of 
Table 1. Sample of questionnaire: Knowledge score – Questions 6 - 8 
Question Response Choice
6.  As far as you know, at what age should 
one start screening a patient for prostate 
cancer?
35 years 1
                           Correct answer → 40 years 2
45 years 3
50 years 4
55 years 5
7.  What is considered to be the level above 
which the prostate-specific antigen (PSA) 
level is interpreted as abnormal? 
1 ng/mL 1
2 ng/mL 2
                           Correct answer → 4 ng/mL 3
6 ng/mL 4
Agree Disagree
Correct 
answer
8.  Please indicate whether you agree or 
disagree with each of the following 
statements: 
A.  A doctor should do PSA testing before 
doing the prostate examination
1 2   2
B.  A prostate examination falsely elevates 
the PSA
1 2 2
C.  Catheterisation gives a false-positive 
PSA result
1 2 1
D.  Obstructive uropathy gives a false-
positive PSA result
1 2 1
E.  Prostatitis gives a false-positive PSA 
result
1 2 1
F. Level of the PSA is age dependent 1 2 1
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all national universities, 45.9% of doctors 
had been trained at the University of the 
Witwatersrand. The two largest groups of 
respondents were interns (35.3%) and regis-
trars (26.7%). Respondents came predomi-
nantly from the field of internal medicine 
(47.9%), followed by primary care practition-
ers (16.6%), general surgeons (16%), surgi-
cal subspecialties (13.5%) and other (10%). 
None of them had specialist urology training.
The mean (SD) knowledge score was 
56.1% (20), with a range of 0 - 100%. Each 
component of the knowledge questionnaire 
was analysed. With regard to age for initiat-
ing prostate cancer screening, 40.3% recom-
mended 40 years, 30% suggested 50 years, 
and 17.8% recommended 45 years (Fig. 1).
The respondents’ knowledge of the causes 
of a false-positive PSA reading is represented 
in Fig. 2. Sixty-six percent of respondents 
thought that the PSA level was age depen-
dent, with 69.6% predicting that the normal 
value was >4 ng/mL. 
The next four questions pertained to the 
doctors’ frequency of practices. Across all four 
items, the frequency of practices (as measured 
by answers of ‘always’ and ‘almost always’) 
appears to be low. Of the four practices, the 
PSA test alone is practised most frequently 
(35.0%), followed by asking the patient about 
urinary tract symptoms (27.7%). In contrast, 
a prostate examination, presumably by DRE, 
on its own, or in conjunction with a PSA test, 
is done less frequently (13.2% and 10.6%, 
respectively) (Fig. 3).
A DRE is not routinely done by 25.7% of 
doctors. No significant gender difference 
was noted (p=0.66). With regard to PSA 
testing, 20.1% never, 44.9% sometimes and 
35.0% always/almost always perform a PSA 
test. A combination of PSA testing and a 
prostate examination is never performed by 
27.7% of doctors, while 61.7% sometimes 
perform both, and only 10.6% perform both.
The next set of questions explored the rea-
sons why doctors do not perform a prostate 
examination (Fig. 4).
Qualitative analysis revealed the follow-
ing reasons for not performing the prostate 
examination: performance of examination 
only where indicated; the doctor not being 
good at preventive medicine; laboratory 
gate-keeping system blocking the doctor 
from doing PSA testing; only enough time 
for the doctor to focus on the acute com-
plaint; it may pass as sexual harassment; 
psychiatry female doctors don’t do DREs; 
the doctor’s finger is too short to reach the 
prostate; low confidence to adequately assess 
the prostate; the DRE is not relevant to the 
doctor’s practice; and the doctor only does a 
DRE if the patient is symptomatic.
There were significant, weak associations 
between gender, and four reasons for not 
performing the prostate examination. In 
all cases, these reasons were more preva-
lent for women than for the men. These 
reasons included no privacy for examina-
tion (p=0.0014); cultural or religious convic-
tions (p=0.013); anticipated patient refusal 
(p=0.0002); and concern about the patient’s 
modesty (p=0.035; Cramér’s V 0.15 - 0.24).
There was a significant, weak association 
between duration of experience and the 
practice of performing a prostate examina-
tion (only) for male patients at the recom-
mended screening age (χ2 test; p=0.014; 
Cramér’s V 0.18). The trend is not very clear, 
but it appears that those who never do the 
prostrate examination are predominantly in 
the >7-year experience categories.
There were significant, weak associations 
between field of practice and all four prac-
tice items (χ2 test; Cramér’s V 0.20 - 0.27) 
(Fig. 5). With regard to enquiring about 
symptoms, this practice was less prevalent 
in general surgery and the surgical sub-
specialties compared with all other areas 
(p=0.001). General surgeons were more 
likely to perform the prostate examination 
only (p<0.0001) as opposed to physicians, 
who were more likely to do only PSA test-
ing (p<0.0001). Primary care practitioners, 
general surgeons and surgical subspecialists 
were more likely to do both the DRE and 
PSA testing (p=0.010).
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Fig. 1. Recommended prostate cancer screening age. 
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Fig. 2. Aetiology of false-positive PSA levels (question 8). (PSA = prostate-specific antigen.)
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Fig. 3. Frequency of respondents’ prostate cancer screening practice. (PSA = prostate-specific antigen.) 
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There was no significant association between 
knowledge score and practice items or rea-
sons for not performing the prostate exami-
nation.
Discussion
Despite the importance of screening for 
prostate cancer, this practice still remains 
low among non-urologists. The age at which 
to start screening for prostate cancer is 
controversial, especially without guidelines 
in place. Blacks are the largest racial group 
in SA, and are also at higher risk of prostate 
cancer. An SA study found that men aged 
˂50 years compared with those >50 years had 
a significantly greater proportion of poorly 
differentiated adenocarcinoma (53%), local-
ly advanced (stage T3 - 4) tumours (56%), 
haematogenous metastases (75%), signifi-
cantly higher serum PSA levels at diagnosis 
(median 74 ng/mL) and shorter survival.[13] 
General consensus therefore dictates that 
screening should begin earlier in blacks than 
in other racial groups. 
In this study, 40.3% of doctors indicated 
that men should be screened when >40 years 
of age, which differs from studies in other 
countries. In a Canadian study, 57.8% of non-
urologists selected to screen patients who were 
>60 years of age, and in a Malaysian study, 
45% selected to screen those who were >50 
years of age.[14,15] Johnson et al.,[16] in the USA, 
found that 68% of responders stated that they 
recommend prostate cancer screening to >75% 
of their patients who are >50 years old and 
74% of responders felt screening was effective. 
In a Jamaican study, the majority (97%) of 
university hospital doctors were aware that 
prostate cancer among Jamaicans account for 
one of the highest incidences in the world, and 
85% believed that screening should begin at 
age 40.[17] Approximately two-fifths (44.4%) 
of these doctors reported that they usually 
encourage their patients to be screened.[17]
In this study it was found that 25.7% of 
doctors do not perform a DRE routinely. 
This is in contrast to a study by Lim and 
Quinlan,[18] who found that 25% of patients 
had undergone a DRE. Leff et al.[19] found that 
41% of doctors reported that they regularly 
performed annual DREs on outpatients. 
For inpatients, 29% perform it as part of 
every consultation, while 56% perform it only 
when clinically indicated.[19] They also showed 
that of the 85 charts analysed, 56% did not 
document a DRE.[19] Turner and Brewster[11] 
found that house officers performed DREs 
frequently; 53% had performed >50 DREs 
and only 15% had performed <30 DREs. 
Findings were infrequently confirmed by 
a colleague who had also examined the 
patient; 37% of respondents indicated that 
their findings were hardly ever confirmed, 
and 47% mentioned that their DRE findings 
were occasionally confirmed.[11] Freeman[14] 
found that for >80% of patients admitted 
to a medical teaching unit there was no 
documentation of a DRE.
Regarding PSA testing in this study, 35.1% 
of respondents always perform a PSA test. 
Lim and Quinlan[18] found that of 89 patients, 
45% had PSA test results. Firzara and Ng[15] 
found that most (94.9%) of their respondents 
would perform a PSA test if they intended to 
screen for prostate cancer. 
In the current study, a combination of 
PSA testing and prostate examination is also 
infrequently performed, with 27.7% never, 
61.7% sometimes, and 10.6% always/almost 
always doing both. Lim and Quinlan[18] also 
reported poor performance rates, with 17% 
of patients having both a DRE and PSA test-
ing. This is in contrast to Pendleton et al.,[10] 
who found that 79% of patients had both 
PSA and DRE findings. McNaughton et al.[17] 
indica ted that nearly all (97%) of the respon-
dents agreed that performing both the PSA 
test and a DRE is more effective in assessing 
the presence of prostate cancer. 
In our setting we therefore have to ask 
why there is such poor performance of this 
practice. Is gender a determining factor? 
In this study there was no significant 
correlation with gender. Leff et al.[19] found 
no correlation with gender of either the 
patient or resident with regard to comfort 
level. In two separate studies it was found 
that female doctors performed less than 
half the number of DREs than their male 
counterparts.[12,14] 
Another consideration is years of experi-
ence since graduation. This study found that 
those who never perform DREs are predomi-
nantly in the >7-year experience category. 
This may be because many doctors become 
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Fig. 4. Reasons of non-urologists for not performing a digital rectal examination. (DRE = digital rectal 
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more experienced and select patients on whom to perform a DRE. 
It could also be that with experience they do not find it useful and 
would rather use PSA testing. Wong et al.[12] found that the number of 
DREs correlated (r=0.37; p<0.01) with the number of years of clinical 
experience, ranging from an average of 29 DREs among physicians 
within 4 years post graduation to an average of 123 DREs per year 
among physicians who had been practising for >20 years. Turner and 
Brewster[11] found that, despite the additional experience gained since 
graduation, exposure to pathology remained limited; 68% of house 
officers had palpated ˂5 clini cally malignant prostate glands.
With regard to medical disciplines, we found that general surgeons 
followed by primary care physicians and internal medicine physicians 
were more likely to assess the prostate than other surgical subspecial-
ties. General surgeons are more likely to perform a rectal examination 
to assess for colorectal pathology and include examination of the 
prostate simultaneously. Lim and Quinlan[18] noted that their medical 
teams were more likely not to perform a DRE (78.3%) than were the 
surgical teams (67.7%). They also noted that more medical patients had 
had PSA testing than had surgical patients (48.1% v. 39.9%). Wong et 
al.[12] noted that fewer of the gastrointestinal fellows would assess the 
prostate compared with primary care and general physicians. 
In this study, 60.7% would never, 24.8% would sometimes, and 
13.9% would always/almost always not perform a DRE because they 
felt uncomfortable. Turner and Brewster[11] found that 16% of doctors 
at the end of their house year were not at all confident about their 
ability to give an opinion based on their DRE findings, 81% were 
reasonably confident, and 2% were very confident.
Finally, the doctors were asked why they do not perform DREs. 
The reasons given in this study were very similar to those given in 
other studies. Hennigan et al.[20] noted that doctors may be embar-
rassed, a patient may refuse, or a chaperone may not be available. One 
doctor stated: ‘I feel quite strongly that in the absence of feedback it 
is an intrusive waste of time carrying out rectal examinations.’[20] 
Wong et al.[12] noted that the lack of comfort may be explained by 
several factors, including inadequate training and physician reluc-
tance to perform a rectal examination on a patient, particularly of 
the opposite gender. Respondents with less experience were more 
likely to cite perceived invasiveness, patient modesty, and anticipated 
patient refusal as reasons for not performing a DRE.[12] Other reasons 
cited for not performing a DRE included cultural-religious convic-
tions, too much trouble, age of patient, limited value/outdated/not 
useful, and too invasive as a routine examination. Leff et al.[19] noted 
that 13% perform the examination for fear of legal liability or because 
they are told to do so. Forty-six percent did not perform the examina-
tion, as they felt it would not provide useful information.[19]
The underperformance of the DRE not only leads to non-detection 
of some prostate cancer cases, but also deprives junior doctors of 
training.[18] Students should start with lectures on the theoretical 
aspects of performing a rectal examination, followed by practical 
tutorials, using aids such as a pelvic trainer.[12] Teaching the physical 
examination on real patients remains an important part of medical 
education, and supervised performance of the DRE in wards and 
clinics by tutors and senior clinicians is still advocated; this should 
continue during postgraduate training.[12]
Study limitations
The preferred sample for this population sample should have been 
385 doctors. The actual sample size of 303 corresponds to a preci-
sion of 5.6% (rather than 5.0%), which is, however, acceptable. Only 
Johannesburg hospitals were included owing to time and resource 
constraints, as the author is a registrar at the Wits academic complex 
and was unable to travel to obtain more samples.
Conclusion
Performance rates of the DRE at our academic institution by doctors 
who are not urologists are very low. This may have significant clinical 
implications. It is recommended that SA prostate cancer screening 
guidelines are needed to institute change. 
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